Related Experiment Video
Updated: Aug 8, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
Hormone therapy in the menopause and breast cancer risk--a review
1Danish Cancer Society, Division for Cancer Epidemiology, Copenhagen, Denmark.
Objectives:
To evaluate the association between use of hormones in the menopause and breast cancer risk.
Methods:
A qualitative review of reports published between 1970 and 1995.
Results:
The risk of breast cancer starts to increase after 5 or more years of hormone use and remains elevated while taking hormones. Use for 10 or more years may be associated with a 30-80% increase in risk. From 2 to 5 years after stopping taking hormones, the risk seems to return to unity. There is no difference in risk between different types of oestrogens and the addition of progestins does not lower the risk.
Conclusions:
Short term use (less than 5 years) seems safe with respect to breast cancer risk, while longer durations of use may be associated with a small, but significant increase in risk.
More Related Videos
Related Concept Videos
Hormonal Regulation
Hormonal Regulation
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Disorders of the Female Reproductive System
Menopause

